Neurosom Partner Company BEL Achieves FDA Goal.

Last month, BEL software SOURCERER achieved FDA 510(k) clearance. “FDA clearance of SOURCERER has been a major goal of our team and for the BEL Quality Management System,” said Dr. Don Tucker, CEO and Founder of BEL Company, and of Neurosom. BEL Company was founded in 2017 after a successful sale of a previous company […]

Can I use my self-directed IRA to invest in private companies?

Diversifying your portfolio when investing in private companies is crucial for managing risk while aiming for higher returns. Alternative assets like private equity, venture capital, and real estate often present higher risks due to their illiquidity and market volatility, but they also offer the potential for substantial rewards. By incorporating a mix of high-risk, high-reward […]

Understanding Equity Crowdfunding: Exploring Opportunities and Limitations in RegCF, RegA+, and RegD 506(c)

Equity crowdfunding has transformed the investment landscape, providing opportunities for companies seeking capital and investors looking to participate in early-stage ventures. However, within this realm, various regulations govern the process, offering distinct opportunities and limitations. To understand their nuances for companies and investors, let’s delve into three significant regulations—RegCF, RegA+, and RegD 506(c). Regulation Crowdfunding […]

Demystifying Investor Classifications and Diverse Paths in Equity Crowdfunding 

In investing, distinctions between accredited and non-accredited investors carry substantial weight, particularly within the dynamic landscape of equity crowdfunding. Let’s explore the avenues of equity crowdfunding accessible to each category.  Accredited Investors vs. Non-Accredited Investors  Accredited Investors:  Accredited investors are individuals or entities meeting stringent criteria stipulated by regulatory bodies like the Securities and Exchange […]

Site Disclaimer

Want to learn more about investing in Regulation Crowdfunding (Reg CF)? Access our investor educational material here.

Important Disclosures

The www.RedCrow.com website (the “Website” or “Site”) is operated by Red Crow Crowd Inc. (“RedCrow”) and owned by Alira Health Transaction Services. Sections of this website are used by Alira Health Transaction Services (FINRA CRD No. 140203), which is a registered broker-dealer and a member of FINRA | SIPC. Information on all FINRA registered broker-dealers can be found on FINRA’s BrokerCheck. All securities-related activity is conducted by Alira Health Transaction Services, located at 1 Grant St, Framingham, Massachusetts 01702. Neither RedCrow or Alira Health Transaction Services provides investment advice or makes investment recommendations on this website; nothing posted on the Site should be construed as such. No communication, through this website or in any other sections of this website or medium should be construed as a recommendation for any security offered on or off this investment platform.

Alternative investments are speculative, involve a high degree of risk and are not suitable for all investors and you should not invest unless you are able to sustain the risk of loss of your entire investment. Complete loss of principal is possible. Private placements are unregistered securities, considered illiquid and long-term investments. Distributions are not guaranteed. Investing in securities involves risks, and there is always the potential of losing money when you invest in securities.

Content provided is for informational purposes only and is not intended to be an offer, invitation or recommendation to buy, sell, subscribe for or issue any securities or a solicitation of any such offer. Information provided does not take into account an investor’s specific objectives or risk profile. Investment decisions should be made based on your objectives and circumstances and in consultation with your own advisors. Alira Health Transaction Services does not provide tax, legal or accounting advice. Please consult with and rely on a qualified professional.

By accessing this website and any pages thereof, you agree to be bound by the Terms of Use.

Form CRS | Regulation Best Interest | Business Continuity Plan | Privacy Policy | Electronic Delivery Consent.